Advertisement

Stufentherapie der Herzinsuffizienz

  • E. Erdmann
Chapter

Zusammenfassung

Nach den 1995 publizierten Guidelines der WHO wird die Herzinsuffizienz zum einen pathophysiologisch, zum anderen klinisch definiert [6]:
  • Pathophysiologische Definition: Das Herz ist nicht mehr in der Lage, die Gewebe genügend mit Blut und Sauerstoff zu versorgen, um den Gewebestoffwechsel in Ruhe oder unter Belastung sicherzustellen. Dies Führt zu charakterirnale etc.) und Subjektiven und objektiven Symptomen.

  • Klinische Definition: Der Begriff „Herzinsuffizienz“ bezieht sich auf das Syndrom aus Atemnot und Müdigkeit, das bei einer nachgewiesenen Herzerkrankung auftritt. Diese Diagnose kann nur gestallt werden, wenn sowohl eine entsprechende Herzerkrankung als auch die typischen und objektiven Symptome vorhanden sind.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    AnandIS, Kalra GS, Ferrari R, Wahi PL, Harris PC, Poole-Wilson PA (1990) Enalapril as initial and sole treatment in severe chronic heart failure with sodium retention. Int J Cardiol 28: 341–346.PubMedCrossRefGoogle Scholar
  2. 2.
    Brater DC (1985) Resistance to loop diuretics. Drugs 30: 427–443.PubMedCrossRefGoogle Scholar
  3. 3.
    CIBIS (Cardiac Insufficiency Bisoprolol Study) (1994) A randomized trial of ß-blockade in heart failure. Circulation 90: 1765–1773.Google Scholar
  4. 4.
    Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson F (1987) Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57: 17–22.PubMedCrossRefGoogle Scholar
  5. 5.
    US Department of Health and Human Services (1995) Clinical practice guideline. Heart failure: management of patients with left-ventricular systolic dysfunction. AHCPR Publication Nr. 94-0613.Google Scholar
  6. 6.
    World Health Organization/Council on Geriatric Cardiology. Task Force on Heart Failure Edu-cation (1995) Concise guide to the management of heart failure.Google Scholar
  7. 7.
    Dzau VJ, Hollenberg NK (1984) Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia. Ann Intern Med 100: 777–782.PubMedGoogle Scholar
  8. 8.
    Elkayam U, Shotan A, Mehra A, Ostrzega E. (1993) Calcium channel blockers in heart failure. J Am Coll Cardiol 22: 139–144.CrossRefGoogle Scholar
  9. 9.
    Erdmann E (1988) Stellenwert der Diuretika bei der Therapie der Herzinsuffizienz. Lancet 11: 36–39.Google Scholar
  10. 10.
    Fischer ML, Gottlieb SS, Plotnick GD, Greenberg NL, Patten RD, Bennet SK, Hamilton BP (1994) Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial. J Am Coll Cardiol 23: 943–950.CrossRefGoogle Scholar
  11. 11.
    FliserD, Schroter M, Neubeck M, Ritz E (1994) Coadministration of thiazides increases the efficacy of loop diuretic even in patients with advanced renal failure. Kidney Int 46: 482–488.CrossRefGoogle Scholar
  12. 12.
    Working Group on Heart Failure of the European Society of Cardiology (1996) Guidelines for the treatment of heart failure. Europ Heart J, in press.Google Scholar
  13. 13.
    Hoes AW, Grobbee DE, Lubsen J, Man in ’t Veld AJ, Does E van der, Hofmann A (1995) Diuretics, ß-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med 123: 481–487.PubMedGoogle Scholar
  14. 14.
    ISIS-1 (Frist International Study of Infarct Survival) (1986) Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction. Lancet 7: 57–65.Google Scholar
  15. 15.
    Leier CV, Cas DL, Metra M (1994) Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J 128: 564–574.PubMedCrossRefGoogle Scholar
  16. 16.
    MacNeill AB, Sutton SJM, Poole-Wilson PA, Lujbsen J (1993) Doppler flow, echocardiography and functional improvement: assessment of nisoldipine therapy (Defiant-Ü-Study). Clinical Trials and Meta-Analysis 28: 267–280.Google Scholar
  17. 17.
    Olsen SL, Gilbertz EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR (1995) Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind ran-domized study. J Am Coll Cardiol 25: 1225–1231.PubMedCrossRefGoogle Scholar
  18. 18.
    Packer, M, Medina N, Yushak M (1984) Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition. Ann Intern Med 100: 782–789.PubMedGoogle Scholar
  19. 19.
    Pouleur H (1994) Improving patient care: some unresolved issues in heart failure. Cardiology 84: 408–412.PubMedCrossRefGoogle Scholar
  20. 20.
    Reicher-Reiss H, Barasch E (1991) Calcium antagonists in patients with heart failure. Drugs 42: 343–364.PubMedCrossRefGoogle Scholar
  21. 21.
    Rousseau MF, Melin J, Benedict CR, Ahn S, Raphael D, Bornemann M, Pouleur H (1994) Effects of nisoldipine therapy on myocardial perfusion and neuro-hormonal status in patients with severe ischaemic left ventricular dysfunction. Eur Heart J 15: 957–964.PubMedGoogle Scholar
  22. 22.
    Schwinger RHG, Bohm M, Erdmann E (1990) Therapie der chronischen Herzinsuffizienz mit ß-Rezeptorenblockern? Dtsch Med Wochenschr 115: 825–831.PubMedCrossRefGoogle Scholar
  23. 23.
    Schwinger RHG, Bohm M, Erland E (1991) Negative inotropic activity of the calcium antago-nists isradipine nifedipine, diltiazem, and verapamil in diseased human myocardium. Am J Hypertens 4: 185–187.Google Scholar
  24. 24.
    Consensus Trial-Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure; results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316: 1429–1436.CrossRefGoogle Scholar
  25. 25.
    SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ven-tricular ejection fractions and congestive heart failure. N Engl J Med 325: 293–302.CrossRefGoogle Scholar
  26. 26.
    Ball SG fur die AIRE-Studien-Prüfer (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342: 821–828.Google Scholar
  27. 27.
    SOLVD Investigators (1992) Effect of enalapril on mortality and the developement of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327: 685–691.CrossRefGoogle Scholar
  28. 28.
    Waagstein F, Bristow MR, Swedberg K et al. (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342: 1441–1446.PubMedCrossRefGoogle Scholar
  29. 29.
    Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbitidy in patients with heart failure. N Engl J Med 336: 525–533.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • E. Erdmann

There are no affiliations available

Personalised recommendations